Ensure Canadians can be among the first to benefit from regenerative medicine research
0 have signed. Let’s get to 25,000!
The cost of treating chronic diseases in Canada is $190B per year and rising.
Regenerative medicine uses stem cell based therapies and technologies to regrow, repair or replace damaged or diseased cells, organs or tissues. It holds significant potential for treating chronic disease and reducing this cost burden.
Stem cell research was pioneered by two Canadians in the 1960s and Canada has been a world leader in this space ever since. But we are in danger of falling behind and losing out on the health an economic advantages this research holds.
Since 2001, the Stem Cell Network (SCN) has transformed stem cell research, bringing it closer to the clinic and marketplace. As the only national network of regenerative medicine researchers, SCN has supported 170 world-class research groups across Canada and provided specialized training for 2,500 young investigators who represent the future of science, technology and medicine.
However, without stable and predictable funding support the Stem Cell Network will come to an end on March 31, 2019. Other nations that are investing in regenerative medicine will be the first to benefit. Their populations will be first in line for new therapies, rather than Canadians. Their economies will see new job opportunities and technologies emerge.
An investment in stem cell research is an investment in the future. We are at a tipping point and now is the time to act.
This is our science. It's Canada's time.
Today: Stem Cell Network is counting on you
Stem Cell Network needs your help with “Kirsty Duncan: Ensure Canadians can be among the first to benefit from regenerative medicine research”. Join Stem Cell Network and 20,972 supporters today.